AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

VSee Health, Inc.

$0.01 -$0.41 (-96.92%)
OTC · 15 Sep 2026 16:22 UTC
Previous Close
$0.01
Day Range
$0.01$0.01
Year Range
$0.01$2.52
Market Cap
211.44K
AVG Volume
6.7M
Trailing/Forward PE
-0.03/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q212.63M
26 Q114.46M
25 Q414.62M
25 Q314.55M
25 Q213.93M
25 Q112.25M
24 Q410.42M
24 Q37.99M
24 Q26.09M
24 Q15.67M
Net Income (USD) · TTM
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-13.82M
26 Q1-13.35M
25 Q4-14.71M
25 Q3-12.48M
25 Q2-63.94M
25 Q1-61.66M
24 Q4-57.7M
24 Q3-54.86M
24 Q2-3.22M
24 Q1-3.31M
Operating Income (USD) · TTM
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-10.02M
26 Q1-9.57M
25 Q4-9.58M
25 Q3-10.08M
25 Q2-65.09M
25 Q1-64.02M
24 Q4-62.15M
24 Q3-58.56M
24 Q2-1.77M
24 Q1-1.2M
EBITDA (USD) · TTM
-10M-7.5M-5M-2.5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-9.03M
26 Q1-8.67M
25 Q4-9.18M
25 Q3-5.55M
25 Q2-7.47M
25 Q1-5.97M
24 Q4-3.36M
24 Q3-1.25M
24 Q2-731.02K
24 Q1-1.12M
Cash Flows (USD) · TTM
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-6.32M
26 Q1-5.5M
25 Q4-3.48M
25 Q3-4.52M
25 Q2-3.99M
25 Q1-5.96M
24 Q4-4.94M
24 Q3-2.27M
24 Q2-2.1M
24 Q1-41.41K
EPS (USD) · TTM
-6-4-2024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.43
26 Q1-0.54
25 Q4-0.73
25 Q3-0.78
25 Q2-4.19
25 Q1-4.09
24 Q4-3.85
24 Q3-3.77
24 Q2-0.35
24 Q1-0.33
Expenses (USD) · TTM
05M10M15M20MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q214.69M
26 Q115.76M
25 Q415.65M
25 Q315.92M
25 Q215.63M
25 Q113.81M
24 Q411.92M
24 Q37.31M
24 Q23.97M
24 Q13.91M
Shares Outstanding (USD) · TTM
-2.5M02.5M5M7.5MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VSEE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-191.11K
26 Q111.45K
25 Q4-380.66K
25 Q3-907.56K
25 Q2-1.26M
25 Q1-1.26M
24 Q4-864.55K
24 Q36.45M
24 Q26.8M
24 Q16.8M
Employee Count
010020030020242025
VSEE Employee Count by quarter
PeriodEmployee Count
2025209
2024154
Free Cash Flow Yield
-1000%-750%-500%-250%0%med -45.74%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VSEE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-841.45%
Sep 26-785.35%
Sep 26-740.9%
Aug 26-736.27%
Aug 26-428.37%
Aug 26-400.69%
Aug 26-396.08%
Jul 26-145.95%
Jul 26-145.4%
Jul 26-118.42%
Jul 26-103.48%
Jul 26-104.42%
Jun 26-105.38%
Jun 26-99.36%
Jun 26-80.89%
Jun 26-72.24%
May 26-60.61%
May 26-71.7%
May 26-64.57%
May 26-95.86%
May 26-90.39%
Apr 26-81.2%
Apr 26-68.74%
Apr 26-74.95%
Apr 26-77.37%
Mar 26-113.84%
Mar 26-105.81%
Mar 26-97.58%
Mar 26-97.58%
Feb 26-74.04%
Feb 26-78.96%
Feb 26-78.28%
Feb 26-77.59%
Jan 26-75.68%
Jan 26-68.01%
Jan 26-62.23%
Jan 26-64.59%
Jan 26-64.77%
Dec 25-62.02%
Dec 25-61.95%
Dec 25-52.94%
Dec 25-49.77%
Nov 25-48.79%
Nov 25-45.83%
Nov 25-36.84%
Nov 25-24.81%
Oct 25-24.89%
Oct 25-39.01%
Oct 25-50.86%
Oct 25-45.64%
Oct 25-49%
Sep 25-49.23%
Sep 25-48.85%
Sep 25-44.85%
Sep 25-46.66%
Aug 25-52.1%
Aug 25-18.38%
Aug 25-19.28%
Aug 25-11.42%
Aug 25-12.46%
Jul 25-11.33%
Jul 25-11.17%
Jul 25-12.36%
Jul 25-12.88%
Jun 25-13.7%
Jun 25-13.83%
Jun 25-14.93%
Jun 25-13.22%
May 25-11.96%
May 25-13.83%
May 25-13.58%
May 25-12.88%
May 25-12.26%
Apr 25-11.87%
Apr 25-12.67%
Apr 25-14.36%
Apr 25-13.22%
Mar 25-13.46%
Mar 25-12.46%
Mar 25-11.87%
Mar 25-11.96%
Feb 25-9.98%
Feb 25-8.28%
Feb 25-8.06%
Feb 25-8.57%
Jan 25-8.97%
Jan 25-9.19%
Jan 25-10.26%
Jan 25-11.42%
Jan 25-11%
Dec 24-11%
Dec 24-11.25%
Dec 24-10.12%
Dec 24-9.42%
Nov 24-7.18%
Nov 24-10.19%
Nov 24-11.17%
Nov 24-30.64%
Nov 24-26.35%
Oct 24-20.69%
Price to Sales
01234med 0.97Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VSEE Price to Sales by quarter
PeriodPrice to Sales
Sep 260.06
Sep 260.06
Sep 260.07
Aug 260.07
Aug 260.12
Aug 260.12
Aug 260.1
Jul 260.26
Jul 260.26
Jul 260.32
Jul 260.37
Jul 260.36
Jun 260.36
Jun 260.38
Jun 260.47
Jun 260.53
May 260.63
May 260.53
May 260.59
May 260.25
May 260.26
Apr 260.29
Apr 260.35
Apr 260.32
Apr 260.31
Mar 260.27
Mar 260.29
Mar 260.32
Mar 260.32
Feb 260.42
Feb 260.39
Feb 260.4
Feb 260.4
Jan 260.41
Jan 260.46
Jan 260.5
Jan 260.48
Jan 260.48
Dec 250.5
Dec 250.5
Dec 250.59
Dec 250.62
Nov 250.64
Nov 250.68
Nov 250.84
Nov 251.15
Oct 251.15
Oct 250.73
Oct 250.56
Oct 251.04
Oct 250.97
Sep 250.96
Sep 250.97
Sep 251.06
Sep 251.02
Aug 250.91
Aug 251.55
Aug 251.48
Aug 252.49
Aug 252.28
Jul 252.51
Jul 252.55
Jul 252.3
Jul 252.21
Jun 252.08
Jun 252.06
Jun 251.91
Jun 252.15
May 252.38
May 252.06
May 252.09
May 252.21
May 252.32
Apr 252.4
Apr 252.25
Apr 251.98
Apr 252.15
Mar 252.11
Mar 252.28
Mar 252.4
Mar 252.38
Feb 252.85
Feb 253.43
Feb 253.53
Feb 253.32
Jan 253.17
Jan 253.09
Jan 252.77
Jan 252.49
Jan 252.59
Dec 242.59
Dec 242.53
Dec 242.81
Dec 243.02
Nov 243.96
Nov 242.79
Nov 242.55
Nov 241.12
Nov 241.31
Oct 241.66
Price to Book
02468med 3.45Nov 24Jan 25Apr 25Jun 25Apr 26Jul 26Sep 26
VSEE Price to Book by quarter
PeriodPrice to Book
Sep 260.1
Sep 260.11
Sep 260.11
Aug 260.11
Aug 260.19
Aug 260.21
Aug 260.22
Jul 260.6
Jul 260.6
Jul 260.74
Jul 260.84
Jul 260.83
Jun 260.83
Jun 260.88
Jun 261.08
Jun 261.2
May 261.44
May 261.21
May 261.35
May 260.66
May 260.71
Apr 260.79
Apr 260.93
Apr 260.85
Apr 260.82
Aug 252.6
Aug 252.48
Aug 254.18
Aug 253.83
Jul 254.21
Jul 254.28
Jul 253.87
Jul 253.71
Jun 253.49
Jun 253.45
Jun 253.2
Jun 253.61
May 253.99
May 253.45
May 253.52
May 253.71
May 253.9
Apr 254.02
Apr 253.77
Apr 253.33
Apr 253.61
Mar 253.55
Mar 253.83
Mar 254.02
Mar 253.99
Feb 254.78
Feb 255.77
Feb 255.92
Feb 255.58
Jan 255.32
Jan 255.2
Jan 254.66
Jan 254.18
Jan 254.34
Dec 244.34
Dec 244.25
Dec 244.72
Dec 245.07
Nov 246.65
Nov 244.69
Nov 244.28
Nov 240.12
Nov 240.15
Oct 240.18
Oct 240.16
Oct 240.11
Oct 240.12
Sep 240.14
VSee Health, Inc.
VSEE
Stockpicker

Video analysis: VSEE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VSEE

VSee Health Poised for Growth

accessnewswire.com · 27 Aug 2026

VSee Health Poised for Growth

VSee Health announces Annual Meeting Results HOUSTON, TX / ACCESS Newswire / August 27, 2026 / VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has identified approximately $1 million in near term annual savings associated with its transition from Nasdaq, the reduction of public-company expenses and the streamlining of its corporate operations. The Company intends to redirect these savings toward revenue-generating growth initiatives, working capital and the continued expansion of its hospital-based telehealth operations.

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

accessnewswire.com · 30 Jul 2026

VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings

The acquisition is expected to close fairly quickly and without any initial shareholder dilution HOUSTON, TX / ACCESS Newswire / July 30, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market.

VSEE Vertically Integrated Healthcare Commerce Platform

accessnewswire.com · 29 Jul 2026

VSEE Vertically Integrated Healthcare Commerce Platform

Proposed acquisition, valued at $42 million, could add over $35 million in annualized revenue and more than $7 million in earnings HOUSTON, TX / ACCESS Newswire / July 29, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth technology and digital health solutions, today announced that it has entered into a non-binding letter of intent (the "LOI") for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market.

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

accessnewswire.com · 28 Jul 2026

VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value

HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value. The Board believes VSee has reached an important inflection point.

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

accessnewswire.com · 22 Jul 2026

VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution

HOUSTON, TX / ACCESS Newswire / July 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals.

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

accessnewswire.com · 14 Jul 2026

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. "We believe healthcare is entering a new technology cycle in which artificial intelligence becomes an operating layer, rather than simply another application," said Dr. Imoigele Aisiku, Chairman and Chief Executive Officer of VSee Health.

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

accessnewswire.com · 9 Jul 2026

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook. Dear Fellow Shareholders, Over the past two years, VSee Health has undergone a significant transformation.

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

accessnewswire.com · 25 Jun 2026

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.